Showing results (271-280 of 432) with videos related to

Sort By:
Pageof 44
Adipocyte|March 18, 2022
Adipose tissue aging partially accounts for fat alterations in HIV lipodystrophyPere Domingo, Marta Giralt, Aleix Gavaldà-Navarro, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 27, 2005
Once-daily regimen of saquinavir, ritonavir, didanosine, and lamivudine in HIV-infected patients with standard tuberculosis therapy (TBQD Study)Esteban Ribera, Carlos Azuaje, Rosa M Lopez, et al.
Revista Espanola De Cardiologia|December 6, 2006
[Clinical characteristics and outcome of infective endocarditis in individuals of the general population managed at a teaching hospital without cardiac surgery facilities. Study of 120 cases]Miguel López-Dupla, Sebastián Hernández, Montserrat Olona, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 26, 2009
Genetic and functional mitochondrial assessment of HIV-infected patients developing HAART-related hyperlactatemiaGlòria Garrabou, Constanza Morén, Jose Miguel Gallego-Escuredo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 12, 2009
Improvement of mitochondrial toxicity in patients receiving a nucleoside reverse-transcriptase inhibitor-sparing strategy: results from the Multicenter Study with Nevirapine and Kaletra (MULTINEKA)Eugenia Negredo, Oscar Miró, Benjamí Rodríguez-Santiago, et al.
Plos One|March 4, 2014
Effects of switching from stavudine to raltegravir on subcutaneous adipose tissue in HIV-infected patients with HIV/HAART-associated lipodystrophy syndrome (HALS). A clinical and molecular studyPere Domingo, María del Mar Gutierrez, José Miguel Gallego-Escuredo, et al.
Antiviral Therapy|February 4, 2012
Evolution of HIV-1 genotype in plasma RNA and peripheral blood mononuclear cells proviral DNA after interruption and resumption of antiretroviral therapyArkaitz Imaz, Montserrat Olmo, Maria Peñaranda, et al.
The Journal of Antimicrobial Chemotherapy|June 25, 2025
48 Week body composition changes in persons with HIV switching to dolutegravir plus lamivudine: a planned subanalysis of the DOLAM randomized clinical trialElisa de Lazzari, Silvana Di Gregorio, Jhon Rojas, et al.
Plos One|August 8, 2024
Evolving trends in neuropsychological profiles of post COVID-19 condition: A 1-year follow-up in individuals with cognitive complaintsNicholas Grunden, Marco Calabria, Carmen García-Sánchez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 10, 2003
Clinical course and prognostic factors of progressive multifocal leukoencephalopathy in patients treated with highly active antiretroviral therapyJuan Berenguer, Pilar Miralles, Julio Arrizabalaga, et al.
Pageof 44